Loading resource…

Tara Daoud, Jesus Villar, Djillali Annane
Corticosteroids have been shown to modulate inflammatory pathways in ARDS, particularly in cases related to COVID-19 and severe pneumonia. The review emphasizes the need for precision medicine approaches, as treatment efficacy varies significantly among different ARDS phenotypes. It also addresses the long-term effects and potential adverse outcomes associated with corticosteroid therapy, suggesting that future research should focus on tailored treatment strategies based on individual patient characteristics.
No account needed